More pandemic profiteers: COVID-19 vaccines have minted at least NINE new pharma billionaires – and their combined wealth is enough to buy shots for 780 MILLION people in low-income nations

Nine executives from Moderna, BioNTech, ROVI and CanSino Biologics have all become billionaires throughout the pandemic
Together they are now worth $19.3 billion – a combined net wealth greater than what it would cost to vaccinate the world’s poorest nations
The list was compiled by the People’s Vaccine Alliance, a campaign group that includes Oxfam, UNAIDS, Global Justice Now and Amnesty International
Moderna CEO Stéphane Bancel is now worth a whopping $4.3 billion after his company was granted emergency use authorization in the US in December
CEO and co-founder of BioNTech Ugur Sahin is close behind with a wealth of $4 billion, following its collaboration on a vaccine with Pfizer
Senior executives from CanSino Biologics have also become billionaires after it developed a one-shot vaccine that was approved for use in China this February
It comes as world leaders will discuss at the G20 Global Health Summit whether to waive patent protections for COVID-19 vaccines
Supporters say it will allow more manufacturers to produce life-saving vaccines and increase their supply to poorer countries